NASDAQ •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 05/04/2026 16:00
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization5,562.77 mln
Float154 mln
Earnings Date05/05/2026
EPS
1.43
Moderate
P / E
23.90
Premium valuation
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-3.31
Reliable
1-Year Forecast
44.53
Strong upside
Relative Strength
51
/ 100
In line with market
Business Description
Alkermes is an Irish biopharmaceutical company founded in 1987 that develops and sells medicines for serious mental health and neurological conditions, including schizophrenia, bipolar disorder, and opioid and alcohol dependence. Its approved treatments are sold primarily in the United States, with additional operations in Ireland and other markets. The company also licenses its drug delivery technology to other pharmaceutical firms, supporting their efforts to develop and manufacture their own products.
